NCT03179904 2026-02-24
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT05743621 2025-11-21
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Weill Medical College of Cornell University
Phase 1 Recruiting
NCT02980029 2024-10-22
TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
University of Kentucky
Phase 1 Terminated
NCT03032484 2023-06-15
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
The University of Texas Health Science Center at San Antonio
Phase 2 Completed